89BIO, INC. (ETNB): Price and Financial Metrics
ETNB Price/Volume Stats
| Current price | $7.94 | 52-week high | $16.63 |
| Prev. close | $7.03 | 52-week low | $6.43 |
| Day low | $6.60 | Volume | 4,504,600 |
| Day high | $7.95 | Avg. volume | 980,337 |
| 50-day MA | $8.42 | Dividend yield | N/A |
| 200-day MA | $8.81 | Market Cap | 842.64M |
ETNB Stock Price Chart Interactive Chart >
89BIO, INC. (ETNB) Company Bio
89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.
ETNB Price Returns
| 1-mo | -5.25% |
| 3-mo | -3.05% |
| 6-mo | -6.04% |
| 1-year | -27.16% |
| 3-year | -38.73% |
| 5-year | -70.46% |
| YTD | -28.92% |
| 2023 | -12.25% |
| 2022 | -2.60% |
| 2021 | -46.37% |
| 2020 | -7.30% |
| 2019 | N/A |
Loading social stream, please wait...